C Mizon

946 total citations
39 papers, 811 citations indexed

About

C Mizon is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, C Mizon has authored 39 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Cell Biology. Recurrent topics in C Mizon's work include Protease and Inhibitor Mechanisms (10 papers), Glycosylation and Glycoproteins Research (9 papers) and Proteoglycans and glycosaminoglycans research (8 papers). C Mizon is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Glycosylation and Glycoproteins Research (9 papers) and Proteoglycans and glycosaminoglycans research (8 papers). C Mizon collaborates with scholars based in France, Switzerland and Belgium. C Mizon's co-authors include J Mizon, Malika Balduyck, Antoine Cortot, Jean‐Frédéric Colombel, Christel Neut, Odile Carrette, É. Hachulla, Thierry Burnouf, M. Jourdain and François Fourrier and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Biochemical and Biophysical Research Communications and European Journal of Biochemistry.

In The Last Decade

C Mizon

39 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Mizon France 16 407 195 153 143 103 39 811
J Mizon France 19 607 1.5× 258 1.3× 176 1.2× 168 1.2× 106 1.0× 63 1.2k
Tomoko Inoue Japan 19 565 1.4× 83 0.4× 45 0.3× 200 1.4× 91 0.9× 50 1.0k
Tomas Bratt Denmark 11 372 0.9× 101 0.5× 56 0.4× 90 0.6× 70 0.7× 21 776
Manujendra N. Saha Canada 20 610 1.5× 50 0.3× 35 0.2× 185 1.3× 61 0.6× 32 1.1k
Xinying Wang China 24 807 2.0× 68 0.3× 79 0.5× 421 2.9× 106 1.0× 68 1.5k
Nancy Matheson United States 14 313 0.8× 68 0.3× 58 0.4× 318 2.2× 44 0.4× 18 1.0k
M K Bijsterbosch Netherlands 17 577 1.4× 61 0.3× 101 0.7× 141 1.0× 70 0.7× 27 1.1k
Xujun He China 23 843 2.1× 101 0.5× 54 0.4× 539 3.8× 67 0.7× 60 1.3k
Philip Marder United States 17 418 1.0× 46 0.2× 51 0.3× 54 0.4× 60 0.6× 45 929
Catherine T. Anthony United States 20 444 1.1× 53 0.3× 164 1.1× 103 0.7× 152 1.5× 39 1.0k

Countries citing papers authored by C Mizon

Since Specialization
Citations

This map shows the geographic impact of C Mizon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Mizon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Mizon more than expected).

Fields of papers citing papers by C Mizon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Mizon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Mizon. The network helps show where C Mizon may publish in the future.

Co-authorship network of co-authors of C Mizon

This figure shows the co-authorship network connecting the top 25 collaborators of C Mizon. A scholar is included among the top collaborators of C Mizon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Mizon. C Mizon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizon, C, et al.. (2002). Urinary Bikunin Determination Provides Insight into Proteinase/Proteinase Inhibitor Imbalance in Patients with Inflammatory Diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 40(6). 579–86. 33 indexed citations
2.
Jean, Laetitia, C Mizon, William J. Larsen, J Mizon, & Jean‐Philippe Salier. (2001). Unmasking a hyaluronan‐binding site of the BX7B type in the H3 heavy chain of the inter‐α‐inhibitor family. European Journal of Biochemistry. 268(3). 544–553. 12 indexed citations
3.
Mizon, C, et al.. (2001). The chondroitin sulfate chain of bikunin‐containing proteins in the inter‐α‐inhibitor family increases in size in inflammatory diseases. European Journal of Biochemistry. 268(9). 2717–2724. 24 indexed citations
4.
Mizon, C. (2000). Human pre-α-inhibitor is a positive acute-phase protein that is more susceptible than inter-α-inhibitor to proteolysis by stimulated neutrophils. European Journal of Clinical Investigation. 30(1). 79–79. 10 indexed citations
5.
Balduyck, Malika, M. Jourdain, C Mizon, et al.. (2000). Inflammation-induced systemic proteolysis of inter-α-inhibitor in plasma from patients with sepsis. Journal of Laboratory and Clinical Medicine. 135(2). 188–198. 39 indexed citations
6.
Carrette, Odile, C Mizon, Charles‐Hugo Marquette, Fermı́n Lampreave, & J Mizon. (1999). Inter-α-Inhibitor (IαI) Concentration in Pig Plasma Is Independent of Acute-Phase Protein Response. Clinical Chemistry and Laboratory Medicine (CCLM). 37(5). 521–525. 1 indexed citations
7.
Flahaut, Christophe, C Mizon, Pierre Colson, et al.. (1998). Disulphide bonds assignment in the inter‐α‐inhibitor heavy chains. European Journal of Biochemistry. 255(1). 107–115. 8 indexed citations
8.
Jourdain, M., Odile Carrette, A. Tournoys, et al.. (1997). Effects of Inter- α -inhibitor in Experimental Endotoxic Shock and Disseminated Intravascular Coagulation. American Journal of Respiratory and Critical Care Medicine. 156(6). 1825–1833. 32 indexed citations
9.
Neut, Christel, et al.. (1997). Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease. Digestive Diseases and Sciences. 42(4). 817–822. 170 indexed citations
10.
Carrette, Odile, C Mizon, Pierre Sáutière, Richard Sesboüé, & J Mizon. (1997). Purification and characterization of pig inter-α-inhibitor and its constitutive heavy chains. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1338(1). 21–30. 11 indexed citations
11.
Mizon, C, et al.. (1997). Human pre-α-inhibitor: isolation from a by-product of industrial scale plasma fractionation and structural analysis of its H3 heavy chain. Journal of Chromatography B Biomedical Sciences and Applications. 692(2). 281–291. 13 indexed citations
12.
13.
Carrette, Odile, C Mizon, Christel Neut, et al.. (1995). Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease. Digestive Diseases and Sciences. 40(12). 2641–2646. 44 indexed citations
14.
Balduyck, Malika, et al.. (1994). Preparation and Properties of a Therapeutic Inter‐Alpha‐Trypsin Inhibitor Concentrate from Human Plasma. Vox Sanguinis. 67(4). 329–336. 28 indexed citations
15.
Balduyck, Malika, Francesco Piva, C Mizon, et al.. (1993). Human Leucocyte Elastase (HLE) Preferentially Cleaves the Heavy Chain H2of Inter-α-Trypsin Inhibitor (ITI). Biological Chemistry Hoppe-Seyler. 374(7-12). 895–902. 17 indexed citations
16.
17.
Balduyck, Malika, et al.. (1991). A chondroitin-sulfate chain is located on serine-10 of the urinary trypsin inhibitor. International Journal of Biochemistry. 23(11). 1201–1203. 12 indexed citations
18.
Wallaert, B., Bernard Gressier, C Aerts, et al.. (1991). Oxidative Inactivation of α 1-Proteinase Inhibitor by Alveolar Macrophages from Healthy Smokers Requires the Presence of Myeloperoxidase. American Journal of Respiratory Cell and Molecular Biology. 5(5). 437–444. 19 indexed citations
19.
Gressier, Bernard, Malika Balduyck, C Mizon, & J Mizon. (1990). Crossed Immunoelectrophoresis Does not Allow Accurate Determination of Inter-α-Trypsin Inhibitor and Its Derivatives in Plasma. Biological Chemistry Hoppe-Seyler. 371(2). 865–870. 4 indexed citations
20.
Mizon, C, et al.. (1988). [Clinical value of the determination of urinary antitrypsin activity].. PubMed. 17(7). 329–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Mizon Breakdown of academic impact, for papers by Tomoko Inoue Breakdown of academic impact, for papers by Tomas Bratt Breakdown of academic impact, for papers by Manujendra N. Saha Breakdown of academic impact, for papers by Xinying Wang Breakdown of academic impact, for papers by Nancy Matheson Breakdown of academic impact, for papers by M K Bijsterbosch Breakdown of academic impact, for papers by Xujun He Breakdown of academic impact, for papers by Philip Marder Breakdown of academic impact, for papers by Catherine T. Anthony
Rankless by CCL
2026